HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cafestol preconditioning attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting ERK/PPARγ pathway.

AbstractOBJECTIVE:
The study was aimed to explore the hepatocellular protective functions of cafestol during hepatic ischemia-reperfusion injury and the possible mechanisms.
METHODS:
Ninety male Balb/c mice were randomly divided into seven groups, including normal control group, L-cafestol(20mg/kg) group, H-cafestol(40mg/kg) group, sham group, IR group, L-cafestol(20mg/kg) + IR group, H-cafestol(40mg/kg) + IR group. Serum liver enzymes (ALT, AST), inflammation mediators, proteins associated with apoptosis and autophagy, indicators linked with ERK/PPARγ pathway, and liver histopathology were measured using ELISA, qRT-PCR, immunohistochemical staining, and western blotting at 2, 8, and 24 hours after reperfusion.
RESULTS:
Our findings confirmed that cafestol preconditioning groups could reduce the levels of ALT and AST, alleviate liver pathological damage, suppress the release of inflammation mediators, inhibit the production of pro-apoptosis protein including caspase-3, caspase-9 and Bax, decrease the expression of autophagy-linked protein including Beclin-1 and LC3, increase anti-apoptosis protein Bcl-2, and restrain the activation of ERK and PPARγ.
CONCLUSION:
Cafestol preconditioning could attenuate inflammatory response, apoptosis and autophagy on hepatic ischemia reperfusion injury by suppressing ERK/PPARγ pathway.
AuthorsJie Ji, Liwei Wu, Jiao Feng, Wenhui Mo, Jianye Wu, Qiang Yu, Sainan Li, Jie Zhang, Weiqi Dai, Xuanfu Xu, Yuqing Mao, Shizan Xu, Kan Chen, Jingjing Li, Chuanyong Guo
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 84 Pg. 106529 (Jul 2020) ISSN: 1878-1705 [Electronic] Netherlands
PMID32344356 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.
Chemical References
  • Apoptosis Regulatory Proteins
  • Diterpenes
  • IL1B protein, mouse
  • Interleukin-1beta
  • PPAR gamma
  • Protective Agents
  • Tnf protein, mouse
  • Tumor Necrosis Factor-alpha
  • cafestol
Topics
  • Animals
  • Apoptosis Regulatory Proteins (genetics, metabolism)
  • Cells, Cultured
  • Diterpenes (administration & dosage)
  • Hepatocytes (drug effects, metabolism)
  • Interleukin-1beta (genetics, metabolism)
  • Liver (blood supply, drug effects, metabolism, pathology)
  • Liver Diseases (drug therapy, genetics, metabolism, pathology)
  • MAP Kinase Signaling System (drug effects)
  • Male
  • Mice, Inbred BALB C
  • PPAR gamma (genetics, metabolism)
  • Protective Agents (administration & dosage)
  • Reperfusion Injury (drug therapy, genetics, metabolism, pathology)
  • Tumor Necrosis Factor-alpha (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: